PhysioStim is a French preclinical CRO dedicated to cardiovascular pharmacology and electrophysiology from discovery stages to clinical development. Whatever the therapeutic areas, we ensure robust and valuable preclinical data on cardiovascular activities and secondary pharmacology to secure in-vivo development and bring new safe therapies to patients. Thanks to our predictive and translational models, we define the POC of drug discovery, we investigate secondary pharmacology with on and off-target liabilities, and we address the safety purpose in order to build and support your IND submission (with mandatory and not mandatory assays).
Physiostim senior scientific team is evolving in a GLP environment, the reactivity and accuracy are our best “signature” for more than 20 years.

Let’s bridge the preclinical gap together, for the success of your clinical applications.